Dr. Goodenowe’s research into the biochemical mechanisms of disease started in 1990.  He invented and developed advanced diagnostic and bioinformatic technologies, designed biochemical precursors, and identified biochemical prodromes of numerous diseases including Alzheimer’s disease and dementia, Parkinson’s disease, multiple sclerosis, stroke, autism, amyotrophic lateral sclerosis (ALS), multiple system atrophy, schizophrenia, bipolar disorder, depression, and cancers of the colon, pancreas, ovary, breast, lung, kidney, esophagus, liver, stomach, and endometria.

At Prodrome Sciences, Dr. Goodenowe is going beyond the diagnosis of disease and has set his sights on figuring out how long the human body can maintain the physical and biological functions of life.